kabutan

KOBAYASHI PHARMA, First Half Ordinary Profit Decreases by 31%

Tue Aug 5, 2025 3:30 pm JST Earnings

4967 KOBAYASHI PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KOBAYASHI PHARMACEUTICAL CO.,LTD. <4967> [TSE Prime] announced its financial results after the market closed on August 5th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending December 2025 (January to June) dropped 30.6% from the same period last year to 7.24 billion yen. Progress toward the full-year plan of 15.3 billion yen was 47.4%, which was higher than the five-year average of 39.5%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the July to December period (second half) is expected to significant drop 51.0% from the same period last year to 8.05 billion yen.

In the most recent three-month period, from April to June (2Q), the consolidated ordinary profit amounted to 4.84 billion yen, a 2.6% decrease compared to the same period last year. The operating profit margin decreased from 12.1% in the same period last year to 11.3%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 73,625 10,406 11,174 7,864 103.4 40.9 Aug 8, 2023 J-GAAP
Jan - Jun, 2024 73,136 9,471 10,434 1,436 19.3 38.8 Aug 8, 2024 J-GAAP
Jan - Jun, 2025 69,018 6,648 7,245 3,167 42.6 47.4 Aug 5, 2025 J-GAAP
YoY -5.6% -29.8% -30.6% +120.5% +120.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 44 Feb 10, 2025 J-GAAP
Jan - Jun, 2025 Results 69,018 6,648 7,245 3,167 42.6 44 Aug 5, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 92,464 15,389 16,427 8,631 116.1 59 Feb 10, 2025 J-GAAP
Jul - Dec, 2025 Guidance 101,982 7,352 8,055 7,333 98.7 60 Aug 5, 2025 J-GAAP
YoY +10.3% -52.2% -51.0% -15.0% -15.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 173,455 25,780 27,330 20,338 268.2 101 Feb 9, 2024 J-GAAP
Dec, 2024 165,600 24,860 26,861 10,067 135.4 102 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 171,000 14,000 15,300 10,500 141.3 104 Feb 10, 2025 J-GAAP
YoY +3.3% -43.7% -43.0% +4.3% +4.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 36,651 4,443 4,973 460 6.2 12.1 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 41,323 7,505 7,487 3,908 52.6 18.2 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 51,141 7,884 8,940 4,723 63.5 15.4 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 32,607 2,535 2,401 1,624 21.9 7.8 May 9, 2025 J-GAAP
Apr - Jun, 2025 36,411 4,113 4,844 1,543 20.8 11.3 Aug 5, 2025 J-GAAP
YoY -0.7% -7.4% -2.6% +235.4% +235.4%

Related Articles